Harvard Bioscience

Harvard Bioscience Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Harvard Bioscience (HBIO) as of Nov 6, 2026 is 186.73. In the previous year, Days Inventory Outstanding (DIO) was 215.51 — a change of -13.35% (lower).

Days Inventory Outstanding

186.73

YoY

-13.35%

Last updated:

Days Inventory Outstanding (DIO) of Harvard Bioscience is 2025 186.73 . Days Inventory Outstanding (DIO) of Harvard Bioscience was 2024 215.51 . It decreases by -13.35% lower compared to the previous year.

The Harvard Bioscience Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2018
158.99 USD
Jan 1, 2019
155.29 USD
Jan 1, 2020
184.43 USD
Jan 1, 2021
196.47 USD
Jan 1, 2022
183.76 USD
Jan 1, 2023
195.36 USD
Jan 1, 2024
215.51 USD
Jan 1, 2025
186.73 USD
The Harvard Bioscience Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
186.73-13.35%
215.51+10.32%
195.36+6.31%
183.76-6.47%
196.47+6.53%
184.43+18.76%
155.29-2.33%
158.99+10.74%
143.57+10.60%
129.82-4.58%
136.05+7.70%
126.33—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Harvard Bioscience Stock analysis

What does Harvard Bioscience do? Harvard Bioscience Inc was founded in 1901 and is headquartered in Holliston, Massachusetts. The company is a global leader in providing instruments, technologies, and complete systems for science and research. Harvard Bioscience has established itself as one of the leading providers of products and solutions in the fields of life sciences and health research with over 100 years of industry experience. The business model of Harvard Bioscience is focused on delivering high-quality products and solutions for research needs. The company is divided into three business segments: Life Science Research Products, Preclinical Surgical Products, and Analytical Instruments. These business segments offer a variety of products, such as instruments for cell and molecular research, gene expression analysis devices, surgical instruments, and instruments for electrophysiology. The Life Science Research segment includes the business units Harvard Apparatus, Molecular Devices, and Denville Scientific. Harvard Apparatus provides instruments for cell and molecular research, physiological instruments, and animal model systems. Molecular Devices specializes in instrumental analysis methods for cell and molecular research. Denville Scientific is a leading supplier of products for cell and molecular biology, including materials for gene and protein expression and cell culture techniques. In the Preclinical Surgical Products segment, Harvard Bioscience operates with the company Hugo Sachs Elektronik. Surgical instruments and complete systems for preclinical research are offered here. These products are popular among scientists worldwide as they have been developed for conducting research with animal models. Analytical Instruments is the segment where the company operates joint ventures to develop instruments for physical, material, and life science research. In this segment, Harvard Bioscience is primarily involved in the joint venture Wasatch Microfluidics, alongside Agilent Technologies, which specializes in the development of instruments for life sciences and biotechnology. As a provider of science and research-related instruments and devices, Harvard Bioscience has a wide range of products to help researchers and scientists enhance their work more effectively. Some of the most popular products from Harvard Bioscience include tissue processing systems, neuroprotection applications, animal model holders, and electrophysiology platforms. Harvard Bioscience also offers a range of products for quality assurance and environmental protection, such as cleanroom and protection devices for material preparation and sterilization. Overall, Harvard Bioscience Inc has an excellent reputation in the industry and is one of the world's leading companies for scientific and research-related products and services. The company constantly strives to improve its products and services and adapts to the needs of its customers. It relies on innovation and continuously works to develop and implement new technologies to meet the demands of the scientific world. Harvard Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harvard Bioscience stock

Days Inventory Outstanding (DIO) of Harvard Bioscience is 186.73 in 2025.

Days Inventory Outstanding (DIO) of Harvard Bioscience changed from 215.51 to 186.73, representing a -13.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Harvard Bioscience since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Harvard Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Harvard Bioscience

All Key Metrics — Harvard Bioscience